Related Experiment Video
Updated: May 23, 2026

A Mouse Model of Lumbar Spine Instability
Published on: April 23, 2021
Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII
Lachlan J Smith1, Guilherme Baldo, Susan Wu
1Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. lachlans@mail.med.upenn.edu
Abstract:
Mucopolysaccharidosis type VII (MPS VII) is characterized by deficient β-glucuronidase (GUSB) activity, which leads to accumulation of chondroitin, heparan and dermatan sulfate glycosaminoglycans (GAGs), and multisystemic disease. MPS VII patients can develop kypho-scoliotic deformity and spinal cord compression due to disease of intervertebral disks, vertebral bodies, and associated tissues. We have previously demonstrated in MPS VII dogs that intervertebral disks degenerate, vertebral bodies have irregular surfaces, and vertebral body epiphyses have reduced calcification, but the pathophysiological mechanisms underlying these changes are unclear. We hypothesized that some of these manifestations could be due to upregulation of destructive proteases, possibly via the binding of GAGs to Toll-like receptor 4 (TLR4), as has been proposed for other tissues in MPS models. In this study, the annulus fibrosus of the intervertebral disk of 6-month-old MPS VII dogs had cathepsin B and K activities that were 117- and 2-fold normal, respectively, which were associated with elevations in mRNA levels for these cathepsins as well as TLR4. The epiphyses of MPS VII dogs had a marked elevation in mRNA for the cartilage-associated gene collagen II, consistent with a developmental delay in the conversion of the cartilage to bone in this region. The spine obtained at autopsy from a young man with MPS VII exhibited similar increased cartilage in the vertebral bodies adjacent to the end plates, disorganization of the intervertebral disks, and irregular vertebral end plate morphology. These data suggest that the pathogenesis of destructive changes in the spine in MPS VII may involve upregulation of cathepsins. Inhibition of destructive proteases, such as cathepsins, might reduce spine disease in patients with MPS VII or related disorders.
Insights
Mucopolysaccharidosis type VII (MPS VII) involves GAG accumulation and spine issues. Upregulated cathepsins and altered collagen II in MPS VII dogs suggest protease inhibition may treat spine disease.
Area of Science:
- Biochemistry
- Genetics
- Orthopedics
Background:
- Mucopolysaccharidosis type VII (MPS VII) results from beta-glucuronidase deficiency, causing glycosaminoglycan (GAG) buildup and multisystemic disease.
- Spinal complications in MPS VII include kyphoscoliosis and cord compression due to intervertebral disk and vertebral body abnormalities.
- Pathophysiological mechanisms for spinal changes in MPS VII remain unclear, though GAG binding to Toll-like receptor 4 (TLR4) is a potential factor.
Purpose of the Study:
- Investigate the role of destructive proteases, specifically cathepsins, in spinal pathogenesis of MPS VII.
- Examine the expression of cathepsins, TLR4, and collagen II in MPS VII canine spines.
- Correlate findings in MPS VII dogs with human MPS VII spinal pathology.
Main Methods:
- Assessed cathepsin B and K activity in the annulus fibrosus of MPS VII dog intervertebral disks.
- Quantified mRNA levels for cathepsins, TLR4, and collagen II in MPS VII dog spinal tissues.
- Examined spinal autopsy tissue from a human MPS VII patient for comparative analysis.
Main Results:
- MPS VII dog intervertebral disks showed significantly elevated cathepsin B (117-fold) and cathepsin K (2-fold) activities.
- Elevated mRNA levels for cathepsins and TLR4 were observed in the annulus fibrosus of MPS VII dogs.
- MPS VII dogs exhibited increased collagen II mRNA in epiphyses, indicating delayed cartilage-to-bone conversion.
- Human MPS VII spine showed similar cartilage accumulation and vertebral abnormalities.
Conclusions:
- Spine disease in MPS VII may involve the upregulation of destructive proteases like cathepsins.
- The findings suggest a potential role for GAG accumulation and TLR4 in MPS VII spinal pathology.
- Inhibiting cathepsins could be a therapeutic strategy for reducing spinal disease in MPS VII patients.
Related Concept Videos
Lysosomal Hydrolases
Degenerative Disc Disease ll: Pathophysiology
Degenerative Disc Disease I: Introduction
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Secondary Spinal Cord Injury llI: Pathophysiology
Bacterial Meningitis II: Pathophysiology